vascular walls. This design allowed for the generation of tissue derived exclusively from circulating cells. To confirm this hypothesis, we increased the number of circulating stem cells by means of mobilization with the granulocyte macrophage colony-stimulating factor (GM-CSF). GM-CSF initiates the release of haematopoietic stem cells and other progenitor cells from bone marrow in the circulation typically leading to a significant increase of leucocytes
.
Material and methods

Animal model
Sixty-four membrane/scaffold systems were implanted in the left ventricular cavums and the infra-renal aortas of 32 pigs and left for 3 days, or 2, 6 or 12 weeks (eight pigs per time-point).
The membrane (Mersilene® band, Ethicon, Norderstedt, Germany) was mounted on a supporting scaffold using a 0.2 mm stainless steel wire. The scaffold consisted of a 10-cm-long piece of 5F coronary angiography catheter with both ends bent to form a curved shape (Fig. 1A) . This special design allowed for delivery of the membrane/scaffold system to the left ventricular cavum (Fig. 1B) and the descending aorta (Fig. 1C) [13] . 
Semi-thin sections and electron microscopy
Results
Animal model
Implantation of the scaffolds was technically straightforward in most cases. In two pigs, the scaffolds could not be adequately
Fig. 1 (A) Membrane (M) and scaffold (SF). (B/C) Cartoon showing membrane/scaffold system placement within the left ventricle (B) and aorta (C). (D) Haematoxylin and eosin stained section of the scaffolds demonstrates the absence of invaded cells. (E) Position of the membrane/scaffold system in the left ventricle as documented by x-ray.
Antibody
Host Dilution Source 
Tissue growth on scaffolds and membranes
An invasion of cells per continuitatem could be excluded given the lack of viable cells on the scaffolds (Fig. 1D) (Fig. 3C-D) . After 12 weeks, smooth muscle cells and fibroblasts were clearly aligned (Fig. 3E) (Fig. 5A-C (Fig. 6A, D) . In situ hybridization showed that c-kit was expressed predominantly in the outer layers of the newly developed tissue.
Contribution of stem cells
In the inner parts of the tissue, especially in those after 6 and 12 weeks, the vast majority of cells had differentiated and lost the stem cell marker c-kit (Fig. 6E, F) .
Immunohistochemical analysis revealed the existence of CD45 -/CD44
ϩ mesenchymal stem cells (Fig. 7A) . These cells showed a differentiation potential into fibroblasts (Fig. 7B ) and endothelial cells (Fig. 7D-F) , but not into smooth muscle cells (Fig. 7C) . The high-mobility group box 1 protein (HMGB1), which has been described to have stem cell attracting properties, was expressed strongly in left ventricular membranes after 2 and 6 weeks; the expression of HMGB1 in aortic membranes was comparatively weaker (Fig. 6B, C) .
Endothelial progenitor cells, characterized by positive staining for CD133, were detected only sporadically. Fig. 8A-C) . (Fig. 8E) .
Stem cell mobilization
Stem cell mobilization with GM-CSF was successful as demonstrated by a significant increase in leucocytes in
Fig. 2 (A) Haematoxylin and eosin staining of newly developed tissue on membranes after 3 days, 2 weeks, 6 weeks, 12 weeks. Scale bar ϭ 1 mm. (B/C) Semi-thin sections of membranes. (B) After 3 days, membranes were coated (for the most part) with activated macrophages. (C) After 2 weeks, macrophages were decreased and spindle-like-cells (arrows) appeared, indicating a higher level of differentiation. (D/E) Specific staining for CD45 (red, nuclei blue) after 3 days (D) and 2 weeks (E). (F) Specific staining for CD14 (red, nuclei blue, 3 days). (G) Specific staining for CD3 (green, nuclei blue, 3 days). 6 weeks after implantation, the abundance of c-kit mRNA was three times greater in animals treated with GM-CSF than in nontreated animals (Fig. 8D). At 6 weeks, tissue formation was significantly more robust in animals that had received stem cell mobilization than in nontreated animals. In animals treated with GM-CSF, the extent of tissue formation after 6 weeks was comparable to that in nontreated animals after 12 weeks (GM-CSF
Similar to the results for c-kit, stem cell mobilization led to a significant 4-fold greater abundance in GATA4 mRNA (an early cardiomyocyte marker) at 6 weeks
Discussion
The aim of our study was to examine the physiological differentiation and transdifferentiation potential of circulating stem cells in the absence of ischaemic or other myocardial damage in an in vivo
Fig. 3 (A) Fibroblasts are stained with vimentin (red), smooth muscle cells are stained with ␣-smooth muscle actin (␣-SMA, green). Colocalization of vimentin and ␣-SMA is typical for myofibroblasts, which appear yellow (arrows). Nuclei are blue (#: implanted membrane). (B) Myofibroblasts specifically stained with anti-non-muscle myosin heavy chain b (SMemb; green); nuclei are blue. (C) Cells expressing myosin heavy chain were stained with MF20 (arrows, green), nuclei are red (#: implanted membrane). (D) Mef2c, a marker of muscle cells, was detected in aortic (Ao) and left ventricular membranes (qRT-PCR; n ϭ 8 per time-point). (E) Electron microscopy image showing clear orientation of cells in the newly developed tissue after 12 weeks. (F) Electron microscopy image showing different types of differentiated cells after 6 weeks (SMC, smooth muscle cell; Fb, fibroblast; rER, rough endoplasmic reticulum). (G) Electron microscopy image showing SMCs and organized collagen fibres (coll). Intracellular dense bodies (arrowhead) indicate terminal differentiation and contractile function of SMCs. Focal adhesion points (arrow) hallmark cellular interaction with the extracellular matrix, implying functional organization.
Fig. 4 (A) Time-dependent expression profile of FGF2 (qRT-PCR; n ϭ 8 per time-point); peak expression occurred after 6 weeks (BM, bone marrow). (B) BS-1 staining of endothelial cells. (C) Localization of endothelial cells in the outer cell layer (anti-vWF). (D) Toluidine blue staining of semi-thin sections demonstrates capillaries in the developed tissue. Endothelial cells are indicated by arrows (L, capillary lumen; #, implanted membrane). (E) Electron microscopy of a capillary structure. (F) Higher magnification of image in (E) shows cell-cell contacts of endothelial cells (arrows) surrounding the lumen.
Fig. 6 (A) qRT-PCR shows time-dependent expression of the stem cell marker CD34 on membranes from both compartments, indicating the contribution of stem cells to tissue formation (n ϭ 8 per time-point). (B-C) Specific staining for HMGB1 (green, arrows), a potential stem cell-attracting factor. More cells are positive for HMGB1 in left ventricular membranes (B) than in aortic membranes (C). Nuclei are blue. #, implanted membrane. (D) Transcription analysis shows time-dependent expression of the stem cell marker c-kit (qRT-PCR; n ϭ 8 per time-point). (E-F) In situ hybridization of c-kit. The outer layers show distinct and specific staining for c-kit (blue), whereas the inner layers have already differentiated and ceased to express c-kit.
BM, bone marrow. Fig. 5 (A [17, 18] .
A major finding of the present study was the existence of cardiomyocyte precursors in left ventricular membranes beginning at 6 weeks after implantation and the absence of these cells in membranes from the aorta even after 12 weeks. These early cardiomyocytes were characterized using different methods and several different targets, making misinterpretation unlikely. GATA4, Nkx2.5 and Fog were used as markers of early cardiomyocyte differentiation. All of these markers have been described to be unequivocally specific for the cardiomyocytic lineage [19] [20] [21] [27] and other cell types [28] [30, 31] and by stimulating growth factor, cytokine and chemokine release by cardiac fibroblasts [32] . These 
